Widely-Used Cancer Drug Curbs Vision Loss in Eye Cancer Patients

Upload: November 25, 2015According to a study authored by Dr. Paul Finger, injections of a widely-used cancer drug curbs vision loss due to radiation treatment of eye cancer.

“This is a major breakthrough for eye cancer patients who are treated with radiation therapy and commonly develop radiation retinopathy. Avastin reduces abnormal blood vessel growth, stops leakage in the eye and the patients wind up seeing better. This is a first.”

Continue reading…

Patient Stories

"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”

Read More


  • This field is for validation purposes and should be left unchanged.